Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Basic Res Cardiol ; 112(2): 13, 2017 03.
Artículo en Inglés | MEDLINE | ID: mdl-28116519

RESUMEN

Several studies have demonstrated the expression of odorant receptors (OR) in various human tissues and their involvement in different physiological and pathophysiological processes. However, the functional role of ORs in the human heart is still unclear. Here, we firstly report the functional characterization of an OR in the human heart. Initial next-generation sequencing analysis revealed the OR expression pattern in the adult and fetal human heart and identified the fatty acid-sensing OR51E1 as the most highly expressed OR in both cardiac development stages. An extensive characterization of the OR51E1 ligand profile by luciferase reporter gene activation assay identified 2-ethylhexanoic acid as a receptor antagonist and various structurally related fatty acids as novel OR51E1 ligands, some of which were detected at receptor-activating concentrations in plasma and epicardial adipose tissue. Functional investigation of the endogenous receptor was carried out by Ca2+ imaging of human stem cell-derived cardiomyocytes. Application of OR51E1 ligands induced negative chronotropic effects that depended on activation of the OR. OR51E1 activation also provoked a negative inotropic action in cardiac trabeculae and slice preparations of human explanted ventricles. These findings indicate that OR51E1 may play a role as metabolic regulator of cardiac function.


Asunto(s)
Ácidos Grasos/metabolismo , Miocardio/metabolismo , Miocitos Cardíacos/metabolismo , Proteínas de Neoplasias/metabolismo , Receptores Acoplados a Proteínas G/metabolismo , Western Blotting , Células Cultivadas , Técnicas de Silenciamiento del Gen , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Inmunohistoquímica , Inmunoprecipitación , Reacción en Cadena de la Polimerasa
3.
Br J Ophthalmol ; 75(10): 629-32, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1954216

RESUMEN

It is suspected that radiation retinopathy is more likely to develop in an eye with preexisting diabetic retinopathy than in a normal eye. However, there is only one report of this occurring, at a radiation dose of 4500 rads. We present a woman with minimal diabetic retinopathy who had breast carcinoma which was treated with chemotherapy but metastasised to the choroid. Within nine months of external beam radiation (3000 rads in fractions of 200 rads) a fulminant retinopathy evolved in that eye, while the non-radiated eye showed no change. The histopathology of radiation and diabetic retinopathy and causes for possible synergism are discussed. As this case report shows, radiation oncologists and ophthalmologists need to be aware of the risk that patients with minimal diabetic retinopathy who have undergone chemotherapy may suffer a dramatic visual loss from radiation therapy despite a radiation dose which is considered adequate, safe, and properly fractionated.


Asunto(s)
Neoplasias de la Coroides/radioterapia , Retinopatía Diabética/complicaciones , Traumatismos por Radiación/etiología , Enfermedades de la Retina/etiología , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Coroides/secundario , Femenino , Angiografía con Fluoresceína , Humanos , Persona de Mediana Edad , Radioterapia/efectos adversos , Dosificación Radioterapéutica
4.
Arch Ophthalmol ; 106(10): 1469-71, 1988 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-3178558

RESUMEN

Many patients with branch retinal vein occlusions can develop significant long-term diminution of vision due to such complications as macular edema, retinal neovascularization, and vitreous hemorrhage. One of us (S.C.) developed a new surgical procedure that involves sectioning or decompression of the common sheath connecting the artery and vein at the crossing where a branch retinal vein occlusion occurs. The patient whose case we report had a visual acuity improvement from 20/200-2 to 20/25+1 eight months after surgery.


Asunto(s)
Oclusión de la Vena Retiniana/cirugía , Femenino , Humanos , Persona de Mediana Edad , Disco Óptico/cirugía , Arteria Retiniana/cirugía , Hemorragia Retiniana/cirugía , Vena Retiniana/cirugía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA